BioSpace News Archive

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the appointment of Oved Amitay as Chief Business Officer.

Families and Schools across America got creative during Red Ribbon Week (October 23-31) for the purpose of educating youth about the importance of a drug-free lifestyle, as part of the National Red Ribbon Photo Contest.

Oasis Senior Advisors is all about providing guidance and support. That’s exactly what the newest member of the company’s leadership team will be doing for franchisees. Sarah Price, a registered nurse with 30 years of experience and a background in upper management, has joined the Bonita Springs-based franchisor

Double-win recognises Diamond’s role supporting Kite Pharma Inc in the development of its breakthrough CAR-T cell cancer therapy

TempTraq® Wearable, Bluetooth Temperature Monitor Provides Peace of Mind for Parents and Home Care Givers, and Sets a New Standard of Care for Hospitals in Europe

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies.

Company committed to improving the lives of people affected by brain disorders earns spot on Top Workplace list and is recognized for unique culture

Tolero Pharmaceuticals, Inc. today announced that new data from three abstracts on the Company’s pipeline of investigational agents will be presented at the 60th Annual Meeting of the American Society of Hematology (ASH), December 1-4 in San Diego, California.

Nordic Nanovector ASA announces that the first patient has been dosed in the Archer-1 trial investigating Betalutin® (177Lu-satetraxetan-lilotomab) in combination with rituximab (RTX) in second-line follicular lymphoma (2L FL).

Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary